AMZN
Amazon.com, Inc.
AMZN has the edge over GENK overall, supported by stronger fundamentals and lower modeled downside.
GENK
GEN Restaurant Group, Inc.
GENK trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
GENK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Strong |
GENK's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
GENK PE Valuation
GENK has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over GENK on the outlook, with more favorable revenue and profitability expectations.
GENK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect GENK's losses to shrink, with revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over GENK on earnings quality, reporting a profit while its opponent remains loss making.
GENK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.89 | -$0.62 |
| Q2 2026 | -$0.84 | -$0.69 |
| Q1 2026 | -$0.75 | -$0.71 |
| Q4 2025 | -$0.59 | -554% |
| Q3 2025 | -$0.27 | -259% |
| Q2 2025 | -$0.15 | -163% |
| Q1 2025 | -$0.04 | -104% |
| Q4 2024 | $0.13 | -94% |
GENK lost $0.89 per share over the past year, and its loss has widened in each of the last 11 quarters.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over GENK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over GENK on profitability, with a higher operating margin.
GENK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $48.7M | -3.3% |
| Q2 2026 | $55.7M | +1.2% |
| Q1 2026 | $53.9M | -6% |
| Q4 2025 | $49.7M | -9% |
| Q3 2025 | $50.4M | +2.7% |
| Q2 2025 | $55M | +2.2% |
| Q1 2025 | $57.3M | +13% |
| Q4 2024 | $54.7M | +21% |
GENK's revenue is shrinking: $49M last quarter, down 3.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | -5 points |
| Q2 2026 | -9.2% | -5.8 points |
| Q1 2026 | -13% | -9.6 points |
| Q4 2025 | -25% | -22 points |
| Q3 2025 | -7.4% | -7.6 points |
| Q2 2025 | -3.4% | -6.4 points |
| Q1 2025 | -3.8% | -4 points |
| Q4 2024 | -2.4% | -0.4 points |
GENK's operating margin was −12% last quarter, down 5 points from the same quarter a year ago, near the bottom of its range since 2020.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
GENK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.9M | +$767K |
| Q2 2026 | -$5.5M | +$835K |
| Q1 2026 | -$667K | +$4M |
| Q4 2025 | -$5.6M | -3516% |
| Q3 2025 | -$7.7M | -$870K |
| Q2 2025 | -$6.3M | -605% |
| Q1 2025 | -$4.7M | -$4.1M |
| Q4 2024 | $165K | -83% |
GENK has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over GENK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
GENK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +17% | +935K shares |
| 1 year | +20% | +1.1M shares |
| 3 years | +52% | +2.2M shares |
| 5 years | +75% | +2.7M shares |
GENK has 6M diluted shares, up 20% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $1,000 |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $200,000 |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $320,000 |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
GENK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -1.6x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
| Q3 2024 | -2.1x | Net Cash |
| Q2 2024 | -2.4x | Net Cash |
| Q1 2024 | -2.0x | Net Cash |
| Q4 2023 | -1.8x | Net Cash |
| Q3 2023 | -1.6x | Net Cash |
GENK has more cash than debt.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
GENK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.8 | Oversold |
| Stochastic | 5.4 | Oversold |
GENK's weekly RSI is 26 (oversold) and its Stochastic is 5 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
GENK PE vs Consumer Cyclical Sector
| Metric | GENK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
GENK has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has stronger trend alignment. AMZN is above 5 of 5 weekly averages versus GENK above 0 of 4.
GENK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.49 | 36% below |
| 20 week MA | $1.75 | 45% below |
| 50 week MA | $1.91 | 50% below |
| 100 week MA | $3.17 | 70% below |
GENK is in a downtrend: it's below all four of its weekly moving averages, and 70% below its 100-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over GENK on returns for 2026, with the stronger performance.
GENK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $17.0 | $7.83 | -54% |
| 2024 | $7.83 | $7.40 | -5.5% |
| 2025 | $7.40 | $2.41 | -67% |
| 2026 YTD | $2.41 | $0.96 | -60% |
GENK has finished every year since 2023 lower, and it's down 60% so far in 2026.